About Magnendo
Magnendo is a company based in Boston (United States) founded in 2024 by Miki Rosenberg and Yoonho Kim. Magnendo has raised $2.25 million across 1 funding round. Magnendo offers products and services including Robotic Guidewire and Neurovascular Robotic System. Magnendo operates in a competitive market with competitors including Route 92 Medical, Autonomix, Balt, Capri-Medical and Neuro Front, among others.
- Headquarter Boston, United States
- Founders Miki Rosenberg, Yoonho Kim
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Magnendo Corp
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.25 M (USD)
in 1 rounds
-
Latest Funding Round
$2.25 M (USD), Seed
Jun 05, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magnendo
Magnendo offers a comprehensive portfolio of products and services, including Robotic Guidewire and Neurovascular Robotic System.
Enables magnetic steering for safer brain vasculature navigation in procedures.
Facilitates telerobotic interventions to treat strokes and aneurysms effectively.
Funding Insights of Magnendo
Magnendo has successfully raised a total of $2.25M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.25 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Magnendo
Investment portfolio details for Magnendo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Magnendo
Detailed financials for Magnendo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magnendo Comparisons
Peer comparison for Magnendo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Magnendo
Magnendo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Route 92 Medical, Autonomix, Balt, Capri-Medical and Neuro Front, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation products for neurointerventional procedures are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices for vascular malformations are developed.
|
|
| Locked | Locked | Locked |
Injectable neurostimulation devices are developed for neurological treatments.
|
|
| Locked | Locked | Locked |
Transformation medicines and neuromodulation devices for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive neurosurgical equipment and neuromodulation technologies are developed.
|
Detailed competitors of Magnendo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magnendo
Complete news archive for Magnendo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magnendo
Magnendo was founded in 2024.
Magnendo is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Yoonho Kim is the current CEO of Magnendo. They have also founded this company.
Magnendo is a funded company, having raised a total of $2.25M across 1 funding round to date.
Magnendo was founded in 2024 in Boston, United States, within the medtech sector focused on neurovascular applications. Devices such as magnetically steerable soft-robotic guidewires are developed for minimally invasive procedures addressing stroke and brain aneurysms. Operations center on improving procedural efficiency and reducing complications in the brains vasculature, with services targeted at healthcare providers to enhance patient outcomes.
Magnendo's top competitors include Route 92 Medical, Autonomix and Neuro Front.
Magnendo offers Robotic Guidewire and Neurovascular Robotic System.